Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

58151AST

CHIRALPAK® AGP (5 μm) HPLC Columns

L × I.D. 15 cm × 4 mm, HPLC Column

Sign Into View Organizational & Contract Pricing
All Photos(1)
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52

product name

CHIRALPAK® AGP HPLC Column, 5 μm particle size, L × I.D. 15 cm × 4 mm

material

stainless steel column

Quality Level

100

Agency

suitable for USP L41

product line

CHIRALPAK®

packaging

pkg of 1 ea

manufacturer/tradename

CHIRALPAK®

parameter

137 bar pressure (2000 psi)
20-30 °C temperature
40 °C max. temp.

technique(s)

HPLC: suitable

L × I.D.

15 cm × 4 mm

matrix

fully porous particle

matrix active group

glycoprotein, alpha1- phase

particle size

5 μm

operating pH

2-8

separation technique

chiral

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Hermansson described the use of natural proteins immobilized onto a silica support for chiral separations in 1983 (1). Proteins contain a large number of chiral centers of one configuration, and many other sites that contribute to the general retention process. CHIRALPAK AGP has the broadest range of selectivity of all protein phases currently available. CHIRALPAK AGP phase uses α1-acid glycoprotein (AGP) as the chiral selector immobilized on spherical 5 μm silica particles. Bonded AGP is a very stable protein that tolerates pure organic solvents, elevated temperatures and pH values from 4 to 7. Operated in reversed-phase mode, CHIRALPAK AGP column separates enantiomers of an extremely broad range of drug substances, such as acids, amines and neutral compounds. The enantioselectivity and retention can easily be regulated by mobile phase pH and ionic strength, and the nature and concentration of the organic modifier.

Features:
  • Direct reversed phase resolution of chiral molecules
  • Stable with a variety of organic modifiers
  • Available in analytical and semi-preparative sizes

(1) Hermansson, J. Direct liquid chromatographic resolution of racemic drugs using a1-acid glycoprotein as the chiral stationary phase. J. Chromatogr. A, 1983, 269, 71-80.

Application


  • Evaluation of R- (-) and S- (+) Clenbuterol enantiomers during a doping cycle or continuous ingestion of contaminated meat using chiral liquid chromatography by LC-TQ-MS: This study demonstrates the use of a chiral HPLC column for the separation of clenbuterol enantiomers in biological samples, providing insights into the detection of doping substances or exposure to contaminated meat (Dolores et al., 2019).

  • Stereochemical characterization of fluorinated 2-(phenanthren-1-yl)propionic acids by enantioselective high performance liquid chromatography analysis and electronic circular dichroism detection: This research highlights the capability of chiral HPLC columns to differentiate between the enantiomers of complex fluorinated compounds, offering a method for detailed analysis crucial in pharmaceutical studies (Bertucci et al., 2012).

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

CHIRALPAK is a registered trademark of Daicel Corp.

Regulatory Information

新产品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service